249 related articles for article (PubMed ID: 26272222)
1. Why most oral insulin formulations do not reach clinical trials.
Lopes M; Simões S; Veiga F; Seiça R; Ribeiro A
Ther Deliv; 2015; 6(8):973-87. PubMed ID: 26272222
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
3. [Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabetics?].
Simon M; Kissel T
Pharm Unserer Zeit; 2001; 30(2):136-41. PubMed ID: 11279984
[No Abstract] [Full Text] [Related]
4. Oral insulin reloaded: a structured approach.
Zijlstra E; Heinemann L; Plum-Mörschel L
J Diabetes Sci Technol; 2014 May; 8(3):458-65. PubMed ID: 24876606
[TBL] [Abstract][Full Text] [Related]
5. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of inhaled insulin.
Mastrandrea LD; Quattrin T
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613
[TBL] [Abstract][Full Text] [Related]
7. The physiological rationale for oral insulin administration.
Arbit E
Diabetes Technol Ther; 2004 Aug; 6(4):510-7. PubMed ID: 15321008
[TBL] [Abstract][Full Text] [Related]
8. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
9. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
Wong CY; Al-Salami H; Dass CR
J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
[TBL] [Abstract][Full Text] [Related]
10. [Intensive insulin therapy: results after ten years].
Laube H
Pharm Unserer Zeit; 2001 Jan; 30(1):40-5. PubMed ID: 11233182
[No Abstract] [Full Text] [Related]
11. [What is new in the treatment of diabetes mellitus?].
Gain T
Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
[No Abstract] [Full Text] [Related]
12. The new insulins.
Crotty S; Reynolds SL
Pediatr Emerg Care; 2007 Dec; 23(12):903-5; quiz 906-7. PubMed ID: 18091602
[TBL] [Abstract][Full Text] [Related]
13. Diabetes medications update.
Childs BP
Kans Nurse; 2004 May; 79(5):4-6. PubMed ID: 15216607
[No Abstract] [Full Text] [Related]
14. A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade.
Easa N; Alany RG; Carew M; Vangala A
Drug Discov Today; 2019 Feb; 24(2):440-451. PubMed ID: 30465877
[TBL] [Abstract][Full Text] [Related]
15. [Antidiabetic therapy in diabetic patients with coronary heart disease].
Faglia E
Minerva Med; 2003 Dec; 94(6):387-99. PubMed ID: 14976467
[TBL] [Abstract][Full Text] [Related]
16. [Recent trends on clinical development of oral insulin delivery systems].
Takeda-Morishita M
Nihon Rinsho; 2015 Dec; 73(12):2134-40. PubMed ID: 26666165
[TBL] [Abstract][Full Text] [Related]
17. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
18. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
Wong CY; Al-Salami H; Dass CR
Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
[TBL] [Abstract][Full Text] [Related]
19. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
Scherbaum WA
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
[TBL] [Abstract][Full Text] [Related]
20. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes.
Damgé C; Socha M; Ubrich N; Maincent P
J Pharm Sci; 2010 Feb; 99(2):879-89. PubMed ID: 19691099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
